CDP 840
Alternative Names: L 765527Latest Information Update: 30 Mar 1999
At a glance
- Originator Celltech Group
- Class Antiasthmatics
- Mechanism of Action Type 4 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma